The mission of the ARPA-H is to accelerate better health outcomes for everyone by supporting the development of high-impact solutions to society's most challenging health problems.
From what I know that the recent clinical trial of the medicine among women in Uganda and South Africa was so successful. Additional trials are ongoing in Argentina, Brazil, Mexico, Peru, South Africa, Thailand and the United States.
Not sure this new medicine is approved by FDA but the recent trial of the medicine among cis-gender women in Uganda and South Africa was so successful that it was halted early. Briefly, twice-yearly injections of Lenacapavir showed overwhelming efficacy for preventing HIV infections compared to standard oral preventative HIV medicines, known as pre-exposure prophylaxis (PrEP).
JYNNEOS is approved for the prevention of smallpox and monkeypox disease in adults 18 years of age and older determined to be at high risk for smallpox or monkeypox infection.
mpox had spread to all 50 states in the United States, as well as Washington, D.C., and Puerto Rico. The United States had the highest number of mpox cases in the world during the outbreak. California had the highest number of mpox cases in the United States.
Just find it in the WHO web: Since the beginning of mpox monitoring in 2022 and until 31 July 2024, 102 977 confirmed cases of mpox due to MPXV clade I and clade II, including 219 deaths, have been reported by 121 countries globally.
Mpox is an infectious viral disease that can occur in humans and other animals. Symptoms include a rash that forms blisters and then crusts over, fever, and swollen lymph nodes.
Remote Sensing Letters is seeking distinguished scholars and experts as well as early career researchers to join our Editorial Board. This is a unique opportunity to contribute to the shaping of scholarly discourse in the theory, science and technology of remote sensing and novel applications of remotely sensed data. Due date for the application is next Sunday!!!
Information Systems Management is currently recruiting for an Editor-in-Chief. This role is a great opportunity for an academic with a strong research background in the field. Due date is tomorrow!
Great news! They are looking for a data editor. The Data Editor will work with the editor-in-chief and associate editors to help improve the quality of published research by ensuring reproducibility in the premier journal in political communication. Due date: September 15 2024.
At the end of 2024 the founding Editor of the Journal of European Public Policy, Jeremy Richardson will be stepping down from his role as co-Editor-in-Chief. They are looking for up to three Associate Editors to work together with the Editor-in-Chief. Due date for the application is Sept 15 2024.
Webinar